Endothelial perturbations and therapeutic strategies in normal tissue radiation damage

Radiat Oncol. 2014 Dec 18:9:266. doi: 10.1186/s13014-014-0266-7.


Most cancer patients are treated with radiotherapy, but the treatment can also damage the surrounding normal tissue. Radiotherapy side-effects diminish patients' quality of life, yet effective biological interventions for normal tissue damage are lacking. Protecting microvascular endothelial cells from the effects of irradiation is emerging as a targeted damage-reduction strategy. We illustrate the concept of the microvasculature as a mediator of overall normal tissue radiation toxicity through cell death, vascular inflammation (hemodynamic and molecular changes) and a change in functional capacity. Endothelial cell targeted therapies that protect against such endothelial cell perturbations and the development of acute normal tissue damage are mostly under preclinical development. Since acute radiation toxicity is a common clinical problem in cutaneous, gastrointestinal and mucosal tissues, we also focus on damage in these tissues.

Publication types

  • Review

MeSH terms

  • Endothelial Cells / drug effects
  • Endothelial Cells / radiation effects*
  • Humans
  • Radiation Injuries / etiology*
  • Radiation Injuries / physiopathology*
  • Radiation Injuries / prevention & control*
  • Radiation-Protective Agents / pharmacology


  • Radiation-Protective Agents